Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pan-FGFR tyrosine kinase inhibitor JNJ-42756493
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
An Efficacy and Safety Study of JNJ-42756493 in Participants With Urothelial Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CR105065, NCI-2015-00818, 2014-002408-26, 42756493BLC2001, NCT02365597
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CR100845, NCI-2013-01952, 2012-000697-34, 42756493EDI1001, JNJ-42756493, NCT01703481
Start Over